Uracil

Uracil

SCHEMBL28405698

COc1c[nH]c(=O)[nH]c1=O.O=c1cc[nH]c(=O)[nH]1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.57
ALDH1A1 P00352 4/20 0.40
LMNA P02545 2/20 0.40
ATAD2 Q6PL18 1/20 0.40
MMP2 P08253 1/20 0.37
KMT2A Q03164 1/20 0.37
DPYD Q12882 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
GAA P10253 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
CYP19A1 P11511 1/20 0.36
TSHR P16473 1/20 0.36
THPO P40225 1/20 0.36
MTOR P42345 1/20 0.36
HTT P42858 1/20 0.36
HBB P68871 1/20 0.36
PMP22 Q01453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102177 0.86 ATAD2 (0.52) ALDH1A1LMNAATAD2KMT2ADPYD
Uracil SCHEMBL28750821 0.78
Thymine SCHEMBL574783 0.77 ATAD2 (0.70) CRBNALDH1A1LMNAATAD2MMP2
Uracil SCHEMBL8235 0.75
Uracil SCHEMBL5089507 0.75
Uracil SCHEMBL11607890 0.75
Uracil SCHEMBL3798527 0.75 CRBN (1.00) CRBNALDH1A1LMNAATAD2MMP2
Fluorouracil SCHEMBL16766745 0.74 ALDH1A1 (0.70) CRBNALDH1A1LMNAATAD2MMP2
5-Bromouracil SCHEMBL27980194 0.74 CRBN (0.63) CRBNALDH1A1LMNAATAD2MMP2
Uracil SCHEMBL28867999 0.73 CRBN (0.85) CRBNALDH1A1LMNAATAD2MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117069785-A Lipid compounds and lipid nanoparticle compositions 中生复诺健生物科技(上海)有限公司 2023-11-17 CN disclosed
CN-111417622-A Sulfonamides and compositions thereof for the treatment of conditions associated with N L RP activity 诺华炎症研究公司 2020-07-14 CN disclosed
CN-111094243-A Compounds and compositions for treating conditions associated with NLRP activity 诺华炎症研究公司 2020-05-01 CN disclosed
CN-111094242-A Compounds and compositions for treating conditions associated with NLRP activity 诺华炎症研究公司 2020-05-01 CN disclosed